Shire Share Discussion Threads

[philanderer] 22/8/2017 21:07

Well done justice, good stuff.

SHP closing stateside at more or less the London closing price.

[justiceforthemany] 22/8/2017 18:35

Oh and I did ask him to look into shorters, especially overseas/US shorters akin to Tiger Global who have butchered the Tesco share price and held in lockdown for years now.

[justiceforthemany] 22/8/2017 18:34

He seems to have called a bottom of sorts for the share price

[philanderer] 22/8/2017 18:21

Good work justice :-)

[justiceforthemany] 22/8/2017 18:05

Interestingly enough I did send the CEO an email this morning where the recent share price performance was discussed. I hope he takes my points on board.

[philanderer] 22/8/2017 18:02

Shire CFO, along with analysts, tries to placate investors after surprise exit news sent shares south

[bili1946] 22/8/2017 17:49

Bill Mordan C.S. also bought ADS's $141.000.......

[romeike] 22/8/2017 16:47

Flemming bought approx £307K of Shire shares. Good sign.

[philanderer] 22/8/2017 13:59

Top article, long read...


Shire: At 52-Week Low, Long-Term Opportunity Appears Significant

[philanderer] 22/8/2017 13:33

Certainly has :-)

£250k may be loose change for him but for me it sends out the right sort of signal, although it does indicate there's no takeover talks in progress.

[swedeee] 22/8/2017 13:08

fleming bought in today?

[philanderer] 22/8/2017 13:07

A very nice purchase by the boss today... 8,400 @ £ 36.6493

[philanderer] 22/8/2017 12:43

Could Trump reverse the rules that Obama introduced regarding the clamp down on overseas acquisitions driven by tax avoidance, that scuttled AbbVie's previous bid for SHP ?

[philanderer] 22/8/2017 12:43

double post again :-)

[justiceforthemany] 22/8/2017 10:50

Those (overseas) shorts holding this down again I see.
FCA, company, IR were informed question is what they do about it.

6350p would be nice

Time for the board to seriously look at the offers if 5000p+

[brain smiley] 22/8/2017 10:26

So far;a very poor bounce back.

[philanderer] 22/8/2017 09:45

Out in force this morning ;-)


22nd aug Jefferies buy tp 5250p
22nd aug Citigroup buy tp 6300p
22nd aug Credit Suisse outperform tp 5350p

reiterations

[philanderer] 22/8/2017 09:45

double post.

[philanderer] 21/8/2017 23:49

Cantor Fitzgerald said market concerns about a profit warning in the wake of the news were misplaced. “Although it comes as a surprise, we think the CFO’s departure is understandable given the stock performance this year,” said the broker. “Shire stock is down 17 per cent year to date while the major indices are up.”

[philanderer] 21/8/2017 21:02

US ADR's closing @ $140.85.... equiv.. 3640p

[ruethewhirl] 21/8/2017 20:57

Found myself saying, all the bad news must be priced in, but then again what was the bad news again?

[philanderer] 21/8/2017 20:46

Barron's comment..


Update: I spoke with Shire (SHPG) CFO Jeff Poulton about his decision to leave, and he was quick to dispel any concerns that his departure was about anything except his desire to pursue a new opportunity. He said that the timing is "never good with these kinds of things," but there's "no smoking gun here." He also pointed out that he'll be staying until the end of the year, and meeting with investors with Shire CEO Flemming Ørnskov.

"When you make a personal decision to leave, people will misperceive that," Poulton said. Poulton also said that calling Shire a specialty-pharmaceutical company is a misnomer, as an overwhelming percentage of revenue now comes from its orphan drug business, a point raised by analyst Evercore ISI analyst Josh Schimmer, who wrote that Shire has "biotech cash flows with a spec pharma valuation" in a note last week.

[philanderer] 21/8/2017 20:29

Telegraph market report.......


Pharma giant Shire sank towards the bottom of the FTSE 100 scoreboard yesterday following the shock departure of its chief financial officer.

Shire said that the well-regarded Jeff Poulton, who shepherded the company through its acquisition of rare disease specialist Dyax and $32bn (£25bn) mega-merger with American pharma firm Baxalta, will remain in the role during the third quarter reporting period.

Investors disagreed with the CFO’s comments that it was the “perfect time” to step down, sending Shire shares sliding 151.5p, or 4pc, to £36.13.

The surprise announcement of Mr Poulton’s move to Indigo Ag comes as Shire finalises the integration of Baxalta and pays down debt residing from the huge takeover agreed to last year.

The Boston-based start-up he is heading to specialises in improving agricultural productivity. Shire was beginning to bear the fruits from its Baxalta purchase with the company beating expectations in its second quarter results earlier this month to swing to a $240m profit.

[justiceforthemany] 21/8/2017 20:15

What is so strange about this massive sell off is that it is seemingly for no reason.

There was nothing bad in the update.

If there are concerns about competition well it is hardly trading on a stretched valuation is it?

P/E of 9.3

Debt concerns post Baxalta are not new either and levels are actually down.

Very strange.

[philanderer] 21/8/2017 18:39

50/50 chance I reckon.